Suliqua uses a combination long-acting insulin and the GLP-1 receptor agonist lixisenatide
The regulations establish the minimum standard
Gopal Grandhige, MD, FACS, Board-Certified Surgeon Last Reviewed: April 20, 2026 BPC-157 has a half-life of approximately 4 to 6 hours when administered via subcutaneous injection, so the peptide itself clears your system relatively quickly
GHK-Cu on 'off' nights: for those using tretinoin two to three times per week, GHK-Cu fills the non-retinoid nights to support repair between doses
Unlike growth factors peptides, which need carrier(s) addition, and are rapidly degraded in human gastric juice, BPC 157, as an antiulcer peptide, is native and resistant to human gastric juice exciding one day period (Sikiric et al., 1993